Do you want to read an article? Please log in or register.
Assessment of the role of small airway dysfunction in relation to exacerbation risk in patients with well controlled asthma (ATLANTIS): an observational study
Asthma
Related content
Asthma
Early and continued asthma control up to week 24 in patients with severe, uncontrolled asthma treated with tezepelumab: Initial results of the real-world ASCENT study
Respir Med
Milger K, Dorscheid D, Gessner C, Hilberg O, Llanos JP, Nåtman J, Urbanski H, Clarke DL, Emmanuel B, Stjepanovic N
doi: 10.1016/j.rmed.2026.109075
COMMENTED
Asthma
A self-controlled case series to evaluate the effects of clinical trial eligibility criteria on biologic-associated reductions in severe asthma exacerbations: an analysis of the CHRONICLE Study
★ 2
Recommended by
Dr. med. Martin Frey, Faculty Member
★ 3
Recommended and commented by
Dr Marcus Hesse, Faculty Member
Eur Respir J
Boakye-Dankwa E, Kiddle SJ, Koo HN, Harper AR, Ambrose CS, Douglas IJ, Quint JK
doi: 10.1183/13993003.02196-2025
Asthma
Rilzabrutinib for patients with moderate-to-severe asthma with uncontrolled symptoms: a double-blind, placebo-controlled, phase 2 study
Lancet Respir Med
Maspero JF, Pavord ID, Wechsler ME, Busse W, Laidlaw TM, Mróz RM, Liu T, Mikol V, Suratt BT, Gereige J, Mannent L, Martincova R
doi: 10.1016/S2213-2600(25)00439-4
Asthma
Asthma exacerbation profile of benralizumab for severe eosinophilic asthma (the BenRex study): a multicentre, prospective cohort study
Lancet Respir Med
Logan J, Martin K, Gillespie L, McConnachie A, Lee WN, Burhan H, Brown T, Faruqi S, Jackson DJ, Kurukulaaratchy R, Mansur AH, Saralaya D, Fowler SJ, Patel P, Brown J, Lordan J, Siddiqui S, Smith SJ, Shah PA, Haldar K, Megremis S, Harrison SA, Brown R, Nelson C, Mistry V, Brown V, Chalmers JD, Djukanovic R, Pavord ID, Heaney LG, Brightling CE, Chaudhuri R
doi: 10.1016/S2213-2600(26)00096-2
Asthma
Burden of Type 2 and Oral Corticosteroids Related Comorbidities in Severe Asthma Patients from the Gulf Countries: A Comparative Study from The ISAR Registry
J Asthma Allergy
Al-Ahmad M, Ali A, Al-Lehebi R, Mahboub B, Friston DA, Carter V, Scelo G, Bulathsinhala L, Beastall A, Price DB
doi: 10.2147/JAA.S555783
Asthma
Benralizumab Reduces Asthma Exacerbations and Costs Among Medicare Beneficiaries with Severe Asthma: The ZEPHYR-5 Study
J Asthma Allergy
Adrish M, DeMartino JK, Carstens D, Jackson M, Schinkel J, Wilson K, Tkacz J
doi: 10.2147/JAA.S568990
COMMENTED
AsthmaCOPD
Expectations Versus Reality in Inhalation Technique-A Case-Control Study of Inhalation Technique in Patients with Asthma or COPD
★ 3
Recommended and commented by
Dr. med. Martin Frey, Faculty Member
J Clin Med
Domagała-Mańczyk I, Miszczuk-Cieśla M, Maskey-Warzęchowska M, Zielecki M, Szczudlik P, Dąbrowska M
doi: 10.3390/jcm14196848
Lung Cancer
Retifanlimab versus placebo in combination with platinum-based chemotherapy in patients with first-line non-squamous or squamous metastatic non-small-cell lung cancer (POD1UM-304): a phase 3, multiregional, placebo-controlled, double-blind, randomised study
Lancet Respir Med
Lu S, Vynnychenko O, Kulyaba Y, Kuchava V, Ibrahim A, Moiseenko F, Arslan C, Nguyen DT, Petrovic M, Cicin I, Bibichadze K, Cil T, Shi J, Olmez OF, Gogishvili M, Artac M, Nguyen HG, Cornfeld M, Tian C, Munteanu MC, Sette CVM, Bondarenko I, POD1UM-304 Study Team
doi: 10.1016/S2213-2600(25)00209-7
Asthma
Symptom burden to characterise, predict, and prevent asthma attacks: a patient-level meta-analysis of randomised trials and translational prospective studies
Lancet Respir Med
Couillard S, Meulmeester FL, Charland P, Lemaire-Paquette S, Howell I, Celis-Preciado C, Lachapelle P, Heaney LG, Bradding P, Mailhot-Larouche S, Ramakrishnan S, Wechsler ME, Brusselle G, Diver SE, Brightling CE, Castro M, Hanania NA, Jackson DJ, Martin N, Moore A, Howarth P, Hardin ME, Gall R, Holweg CTJ, Dharman V, Beasley RW, Sont JK, Steyerberg EW, Pavord ID, Oxford Asthma Attack Risk Scale Meta-analysis (ORACLE2) Consortium
doi: 10.1016/S2213-2600(26)00150-5